entertainment -WSS

entertainment

author：fashion 2025-09-29 12:30:22 - browse：57

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The UK government moves asylum

WSS

New air purifier tech could be key to improving indoor air quality

23andMe had bad news about my health. I wish a person had delivered it

'The Exorcist' director William Friedkin dead at 87

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

'The Exorcist' director William Friedkin dead at 87

At least 12 people were injured in a blast at a port in northwest Turkey

knowledge

entertainment

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Illinois to ban advertising for guns allegedly marketed to kids and militants

Peter Hotez and the public health issue of online harassment

At least 13 dead in Texas as scorching temps continue

Trump demands the U.S. pay no more for drugs than other countries … again

Trump demands the U.S. pay no more for drugs than other countries … again

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

focus

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cancer drug shortages should be causing more outrage

After affirmative action ruling, medical educators look to 'holistic review'

The UK government moves asylum

focus

focus

hotspot

hotspot